Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of a Clinical Pharmacist Service on Health-related Quality of Life

This study has been completed.
Sponsor:
Information provided by:
Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT01016301
First received: November 18, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

The aim of the present study is to evaluate effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs. A randomized controlled trial is performed in two internal medicine wards at Sahlgrenska University Hospital, Göteborg, Sweden.


Condition Intervention
Health-Related Quality of Life
Other: Pharmacist service

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Primary Purpose: Health Services Research
Official Title: Effects of a Clinical Pharmacist Service on Health-related Quality of Life

Further study details as provided by Sahlgrenska University Hospital, Sweden:

Primary Outcome Measures:
  • Health-related quality of life [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Prescribing of drugs [ Designated as safety issue: No ]

Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Pharmacist service,
The pharmacist service consists of medication review, drug treatment discussion with the patient, and a medication report.
Other: Pharmacist service
No Intervention: Control Other: Pharmacist service

  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • All patients admitted to the wards during week days after decision of a ward physician or nurse if the medical condition allows inclusion

Exclusion Criteria:

  • Exclusion criteria are poor Swedish language and planned discharge before the intervention can be performed.
  • Patients transferred to wards not belonging to the department of medicine or other hospitals during the hospital stay are also excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01016301

Locations
Sweden
Sahlgrenska University Hospital
Mölndal, Sweden, 431 80
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
  More Information

No publications provided

Responsible Party: Sahlgrenska University Hospital
ClinicalTrials.gov Identifier: NCT01016301     History of Changes
Other Study ID Numbers: CPS1
Study First Received: November 18, 2009
Last Updated: November 18, 2009
Health Authority: Sweden: Regional ethics committee

ClinicalTrials.gov processed this record on November 25, 2014